CORD-19:cb16d307afaecebd683e6d74c8b501ed54b0c9a4 / 60854-61142 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T348","span":{"begin":0,"end":288},"obj":"Sentence"},{"id":"T42800","span":{"begin":0,"end":288},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Ochiai et al. [87] synthesized several 4,4-dimethylpyrazolone analogues as cyclic 30,50-nucleotide PDE 3/4-inhibitor, in which the compound 179 (Fig. 19 ) was demonstrated to be the most potent compound inhibiting PDE 3A and PDE 4B with the IC 50 values of 0.14 and 0.15 mM, respectively."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T62","span":{"begin":0,"end":288},"obj":"Sentence"}],"text":"Ochiai et al. [87] synthesized several 4,4-dimethylpyrazolone analogues as cyclic 30,50-nucleotide PDE 3/4-inhibitor, in which the compound 179 (Fig. 19 ) was demonstrated to be the most potent compound inhibiting PDE 3A and PDE 4B with the IC 50 values of 0.14 and 0.15 mM, respectively."}